Literature DB >> 21725838

Elevated serum IgG4 is associated with chronic antibiotic-refractory pouchitis.

Udayakumar Navaneethan1, Preethi G K Venkatesh, Sumit Kapoor, Ravi P Kiran, Feza H Remzi, Bo Shen.   

Abstract

BACKGROUND AND AIM: We recently reported mucosal infiltration of IgG4-expressing plasma cells in a patient with chronic antibiotic-refractory pouchitis (CARP). The role of serum IgG4 in the pathogenesis and clinical course of ileal pouch disorders has not been investigated. We hypothesized that IgG4-mediated autoimmunity may be a contributing factor in for CARP. The aims of the study were to investigate the prevalence of elevated serum IgG4 in symptomatic patients with ileal pouches and to characterize clinical features of pouch disorders in these patients.
METHODS: A total of 124 consecutive symptomatic patients with ileal pouches from our subspecialty Pouchitis Clinic were enrolled in the study from January to October 2010. Serum IgG4 was measured at the time of presentation. Demographic, clinical, and laboratory characteristics were compared between the study (with serum IgG4 ≥112 mg/dl) and control (with serum IgG4 <112 mg/dl) groups.
RESULTS: There were ten patients (8.0%) with high serum IgG4 in the study group, while the remaining 114 (92%) patients were in the control group. The prevalence of elevated serum IgG4 in this series was 8%. None of the patients had a confirmed diagnosis of autoimmune pancreatitis. The median serum IgG4 in the study group was 144.5 vs. 14 mg/dl in the control group. The mean age of patients in the study and control groups was 35.5 ± 14.5 and 42.0 ± 13.2 years, respectively (p = 0.137). Two patients in the study group (20.0%) had concurrent autoimmune disorders as compared to 19 patients (16.7%) in the control group (p = 0.788). Three (30.0%) patients in the study group had coexisting primary sclerosing cholangitis (PSC) in contrast to 15 (13.2%) in the control group (p = 0.147). Among the study group patients, five (50.0%) had CARP and one (10%) had Crohn's disease (CD) of the pouch, while in the control group, 23 (20.2%) had CARP and 24 (21.1%) patients had CD of the pouch (p = 0.273). CARP was more commonly seen in patients with high serum IgG4 than patients with a normal IgG4 (50.0% vs. 20.2%, p = 0.03).
CONCLUSIONS: Approximately 8% of pouch patients presenting with symptoms of pouch dysfunction to our clinic had elevated serum IgG4. Patients with elevated serum IgG4 were more likely to have CARP.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21725838     DOI: 10.1007/s11605-011-1587-6

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  21 in total

1.  Lymphoplasmacytic sclerosing pancreatitis is a pancreatic lesion of IgG4-related systemic disease.

Authors:  Terumi Kamisawa; Nobuaki Funata; Yukiko Hayashi
Journal:  Am J Surg Pathol       Date:  2004-08       Impact factor: 6.394

2.  IgG4-associated pouchitis.

Authors:  Bo Shen; Ana E Bennett; Udayakumar Navaneethan
Journal:  Inflamm Bowel Dis       Date:  2010-08-18       Impact factor: 5.325

3.  High serum IgG4 concentrations in patients with sclerosing pancreatitis.

Authors:  H Hamano; S Kawa; A Horiuchi; H Unno; N Furuya; T Akamatsu; M Fukushima; T Nikaido; K Nakayama; N Usuda; K Kiyosawa
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

4.  Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience.

Authors:  Suresh T Chari; Thomas C Smyrk; Michael J Levy; Mark D Topazian; Naoki Takahashi; Lizhi Zhang; Jonathan E Clain; Randall K Pearson; Bret T Petersen; Santhi Swaroop Vege; Michael B Farnell
Journal:  Clin Gastroenterol Hepatol       Date:  2006-07-14       Impact factor: 11.382

5.  Inflammatory bowel disease in the setting of autoimmune pancreatitis.

Authors:  Karthik Ravi; Suresh T Chari; Santhi S Vege; William J Sandborn; Thomas C Smyrk; Edward V Loftus
Journal:  Inflamm Bowel Dis       Date:  2009-09       Impact factor: 5.325

Review 6.  Recent advances in autoimmune pancreatitis.

Authors:  D H Park; M-H Kim; S T Chari
Journal:  Gut       Date:  2009-02-24       Impact factor: 23.059

7.  Autoimmune pancreatitis: frequency, IgG4 expression, and clonality of T and B cells.

Authors:  Motohiro Kojima; Bence Sipos; Wolfram Klapper; Olaf Frahm; Hans-Christian Knuth; Akio Yanagisawa; Giuseppe Zamboni; Toshio Morohoshi; Günter Klöppel
Journal:  Am J Surg Pathol       Date:  2007-04       Impact factor: 6.394

8.  Modified pouchitis disease activity index: a simplified approach to the diagnosis of pouchitis.

Authors:  Bo Shen; Jean-Paul Achkar; Jason T Connor; Adrian H Ormsby; Feza H Remzi; Charles L Bevins; Aaron Brzezinski; Marlene L Bambrick; Victor W Fazio; Bret A Lashner
Journal:  Dis Colon Rectum       Date:  2003-06       Impact factor: 4.585

9.  Rituximab therapy for refractory biliary strictures in immunoglobulin G4-associated cholangitis.

Authors:  Mark Topazian; Thomas E Witzig; Thomas C Smyrk; Jose S Pulido; Michael J Levy; Patrick S Kamath; Suresh T Chari
Journal:  Clin Gastroenterol Hepatol       Date:  2008-03       Impact factor: 11.382

10.  The use of immunoglobulin g4 immunostaining in diagnosing pancreatic and extrapancreatic involvement in autoimmune pancreatitis.

Authors:  Maesha G Deheragoda; Nicholas I Church; Manuel Rodriguez-Justo; Philippa Munson; Neomal Sandanayake; Edward W Seward; Keith Miller; Marco Novelli; Adrian R W Hatfield; Stephen P Pereira; George J M Webster
Journal:  Clin Gastroenterol Hepatol       Date:  2007-08-16       Impact factor: 11.382

View more
  6 in total

Review 1.  Acute and chronic pouchitis--pathogenesis, diagnosis and treatment.

Authors:  Bo Shen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-04-17       Impact factor: 46.802

2.  Update on the pathogenesis and management of pouchitis.

Authors:  Saleem Chowdhry; Jeffry A Katz
Journal:  Curr Infect Dis Rep       Date:  2014-12       Impact factor: 3.725

Review 3.  Orbital inflammation and colitis in pediatric IgG4-related disease: A case report and review of the literature.

Authors:  Lissy Tille; Anja Schnabel; Martin W Laass; Gabriele Hahn; Heike Taut; Anna Leszczynska; Jessica Pablik; Reinhard Berner; Normi Brück; Christian M Hedrich
Journal:  Eur J Rheumatol       Date:  2019-12-03

Review 4.  Review article: the pathogenesis of pouchitis.

Authors:  K M Schieffer; E D Williams; G S Yochum; W A Koltun
Journal:  Aliment Pharmacol Ther       Date:  2016-08-24       Impact factor: 8.171

5.  Pre-pouch Ileitis is Associated with Development of Crohn's Disease-like Complications and Pouch Failure.

Authors:  Gaurav Syal; Ron Shemtov; Nirupama Bonthala; Eric A Vasiliauskas; Edward J Feldman; Karen Zaghiyan; Christina Y Ha; Dermot P B McGovern; Stephan R Targan; Gil Y Melmed; Phillip R Fleshner
Journal:  J Crohns Colitis       Date:  2021-06-22       Impact factor: 9.071

6.  High level of IgG4 as a biomarker for a new subset of inflammatory bowel disease.

Authors:  Zhujun Wang; Min Zhu; Chengxin Luo; Yu Zhen; Jingxi Mu; Wenyan Zhang; Qin Ouyang; Hu Zhang
Journal:  Sci Rep       Date:  2018-07-03       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.